Get started
Author

Sæmundur Rögnvaldsson

Observed names: Rögnvaldsson, Sæmundur, S. Rögnvaldsson, Saemundur Rognvaldsson, Saemundur Rögnvaldsson, Samundur Rognvaldsson, Sæmundur Rognvaldsson
Observed institutions: Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center, University of Iceland, Sahlgrenska University Hospital, National University Hospital of Iceland, University of Gothenburg
ORCID: 0000-0003-2162-8414
Observed ORCID: 0000-0003-2162-8414
OpenAlex ID: A5070336544
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
2022 · Thorir Einarsson Long, Olafur Skuli Indridason, et al. · Blood Cancer Journal · 153
PDF
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
2021 · Sæmundur Rögnvaldsson, Thorvardur Jon Love, et al. · Blood Cancer Journal · 131
PDF
Prevalence of smoldering multiple myeloma based on nationwide screening
2023 · Sigrún Thorsteinsdóttir, Gauti K. Gíslason, et al. · Nature Medicine · 93
PDF
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study
2023 · Aðalbjörg Ýr Sigurbergsdóttir, Sæmundur Rögnvaldsson, et al. · Haematologica · 50
PDF
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
2024 · Molly Went, Laura Duran-Lozano, et al. · Nature Communications · 30
PDF
Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls
2020 · Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, et al. · Haematologica · 25
PDF
Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study
2023 · Thorir Einarsson Long, Sæmundur Rögnvaldsson, et al. · Blood · 24
Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study
2021 · Sigurdur Y Kristinsson, Sæmundur Rögnvaldsson, et al. · Blood · 24
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
2025 · Thorir Einarsson Long, Saemundur Rognvaldsson, et al. · JAMA Oncology · 22
PDF
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance
2024 · Elias Eythorsson, Saemundur Rognvaldsson, et al. · Annals of Internal Medicine · 20
PDF
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
2023 · Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, et al. · Blood Cancer Journal · 18
PDF
Prevalence of MGUS Is High in the Istopmm Study but the Prevalence of IgA MGUS Does Not Increase with Age in the Way Other Immunoglobulin Subtypes Do
2022 · Thorvardur Jon Love, Sæmundur Rögnvaldsson, et al. · Blood · 13
Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study
2022 · S. Snorradottir, A. Asgeirsdottir, et al. · Cancer Epidemiology · 13
Prevalence of Smoldering Multiple Myeloma: Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study
2021 · Sigrun Thorsteinsdottir, Gauti Kjartan Gislason, et al. · Blood · 13
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study
2024 · Sæmundur Rögnvaldsson, Alessandro Gasparini, et al. · British Journal of Haematology · 12
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study
2023 · Oihane Pérez-Escurza, Juan Flores-Montero, et al. · Blood Cancer Journal · 12
PDF
Validity of chronic disease diagnoses in Icelandic healthcare registries
2021 · Sæmundur Rögnvaldsson, Thorir Einarsson Long, et al. · Scandinavian Journal of Public Health · 12
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
2021 · Saemundur Rognvaldsson, Elias Eythorsson, et al. · Blood Cancer Journal · 12
PDF
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era
2020 · Vilhjálmur Steingrímsson, Gauti Kjartan Gíslason, et al. · European Journal Of Haematology · 12
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study
2024 · Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, et al. · Blood Cancer Journal · 11
PDF
Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis
2025 · Cecilie Velsoe Maeng, Sæmundur Rögnvaldsson, et al. · Blood Cancer Journal · 10
PDF
Screening in Multiple Myeloma and Its Precursors: Are We There Yet?
2024 · Sæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, et al. · Clinical Chemistry · 10
PDF
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
2021 · Urvi A. Shah, Sæmundur Rögnvaldsson, et al. · Haematologica · 10
PDF
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance
2024 · Ingigerdur Sverrisdottir, Sigrun Thorsteinsdottir, et al. · Annals of Internal Medicine · 9
The Early Benefits and Psychological Effects of Screening for Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study
2023 · Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al. · Blood · 9
Works count: 92
Citation count: 825
H-index: 13
I10-index: 23
Year
Topic
Type